# Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease

> **NCT05194007** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mohammed Bin Rashid University of Medicine and Health Sciences** · enrollment: 13 (actual)

## Conditions studied

- Ulcerative Colitis Chronic Mild
- Ulcerative Colitis Chronic Moderate
- Crohn Colitis

## Interventions

- **DRUG:** Frondanol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05194007
- **Lead sponsor:** Mohammed Bin Rashid University of Medicine and Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-19
- **Primary completion:** 2024-11-19
- **Final completion:** 2024-11-19
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05194007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05194007, "Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05194007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*